Altogether, it is assumed that BRAF mutation-mediated ERK phosphorylation can change the activity of these transcription factor-mediated gene expressions dynamically in cancer cells and exhibit tumor phenotypes. This evidence concerns the gene MAPK1 and neoplasm.